E-7386 IS NOT A SPECIFIC CBP/β-CATENIN ANTAGONIST

ABSTRACT: Our data show that E-7386 which has been reported to be a “first-in-class orally active CBP/beta-catenin modulator” anticancer agent, unfortunately by multiple criteria does not appear to be a bona fide CBP/β-catenin selective

ORGANISM(S): Homo sapiens

PROVIDER: GSE221795 | GEO | 2023/12/31

REPOSITORIES: GEO